Paxman AB (publ) (STO:PAX)
Sweden · Delayed Price · Currency is SEK 53.00
+2.00 (3.92%)
Mar 2, 2026, 5:24 PM CET
Paxman AB Market Cap
Paxman AB has a market cap or net worth of 1.23 billion as of March 2, 2026. Its market cap has decreased by -6.25% in one year.
Market Cap
1.23B
Enterprise Value
1.13B
Revenue
323.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
53.00
Market Cap Chart
Since June 12, 2017, Paxman AB's market cap has increased from 174.54M to 1.23B, an increase of 606.72%. That is a compound annual growth rate of 25.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.19B | -9.25% |
| Dec 30, 2025 | 1.31B | 4.87% |
| Dec 30, 2024 | 1.25B | 78.26% |
| Dec 29, 2023 | 699.66M | -14.62% |
| Dec 30, 2022 | 819.44M | -33.69% |
| Dec 30, 2021 | 1.24B | 203.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.62B |
| BICO Group AB | 1.26B |
| C-Rad AB | 881.32M |
| Sedana Medical AB | 873.17M |
| Senzime AB | 707.47M |
| OssDsign AB | 691.41M |
| Bactiguard Holding AB | 564.21M |
| Q-linea AB | 465.76M |